Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Cytokinetics
(NQ:
CYTK
)
19.19
USD
-0.49 (-2.49%)
Official Closing Price
Updated: 5:22 PM EST, Mar 8, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,152,764
Open
19.76
Bid (Size)
19.10 (1)
Ask (Size)
22.00 (10)
Prev. Close
19.68
Today's Range
19.14 - 20.20
52wk Range
8.000 - 30.14
Shares Outstanding
54,197,546
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Cytokinetics to Participate in Upcoming Investor Conferences
March 02, 2021
From
GlobeNewswire News Releases
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 26, 2021
From
GlobeNewswire News Releases
Performance
YTD
-1.89%
-1.89%
1 Month
-19.20%
-19.20%
3 Month
+17.66%
+17.66%
6 Month
-14.71%
-14.71%
1 Year
+44.07%
+44.07%
More News
Read More
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
February 26, 2021
From
GlobeNewswire News Releases
Cytokinetics Reports Fourth Quarter 2020 Financial Results
February 25, 2021
From
GlobeNewswire News Releases
Cytokinetics Names Muna Bhanji to Board of Directors
February 18, 2021
From
GlobeNewswire News Releases
Cytokinetics to Announce Fourth Quarter Results on February 25, 2021
February 11, 2021
From
GlobeNewswire News Releases
Cytokinetics Announces Recipients of Third Annual Communications Fellowship Grants
February 02, 2021
From
GlobeNewswire News Releases
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 01, 2021
From
GlobeNewswire News Releases
Cytokinetics Announces First Patient Dosed in Cohort 2 of Redwood-HCM
January 13, 2021
From
GlobeNewswire News Releases
Cytokinetics Granted Orphan Drug Designation for CK-3773274 for the Treatment of Hypertrophic Cardiomyopathy
January 11, 2021
From
GlobeNewswire News Releases
Cytokinetics to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
January 06, 2021
From
GlobeNewswire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.